Human Cell Biology ELISA Kits 5
Human VEGF-B (Vascular Endothelial Cell Growth Factor B) CLIA Kit (HUES01143)
- SKU:
- HUES01143
- Product Type:
- ELISA Kit
- ELISA Type:
- CLIA Kit
- Size:
- 96 Assays
- Sensitivity:
- 4.69pg/mL
- Range:
- 7.81-500pg/mL
- ELISA Type:
- Sandwich
- Synonyms:
- VEGFB, VEGFL, VRF
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cell Biology
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection method: | Chemiluminescence |
Detection range: | 7.81-500 pg/mL |
Sensitivity: | 4.69 pg/mL |
Sample volume: | 100µL |
Sample type: | Serum, plasma and other biological fluids |
Repeatability: | CV < 15% |
Specificity: | This kit recognizes Human VEGF-B in samples. No significant cross-reactivity or interference between Human VEGF-B and analogues was observed. |
This kit uses Sandwich-CLIA as the method. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Human VEGF-B. Standards or samples are added to the appropriate micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human VEGF-B and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human VEGF-B, biotinylated detection antibody and Avidin-HRP conjugate will appear fluorescence. The Relative light unit (RLU) value is measured spectrophotometrically by the Chemiluminescence immunoassay analyzer. The RLU value is positively associated with the concentration of Human VEGF-B. The concentration of Human VEGF-B in the samples can be calculated by comparing the RLU of the samples to the standard curve.
UniProt Protein Function: | VEGFB: Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis. Homodimer; disulfide-linked. Can also form heterodimer with VEGF. Expressed in all tissues except liver. Highest levels found in heart, skeletal muscle and pancreas. Belongs to the PDGF/VEGF growth factor family. 2 isoforms of the human protein are produced by alternative splicing. |
UniProt Protein Details: | Protein type:Secreted, signal peptide; Secreted; Cell cycle regulation; Motility/polarity/chemotaxis; Cytokine Chromosomal Location of Human Ortholog: 11q13 Cellular Component: extracellular region Molecular Function:protein binding Biological Process: platelet degranulation; vascular endothelial growth factor receptor signaling pathway |
NCBI Summary: | This gene encodes a member of the PDGF (platelet-derived growth factor)/VEGF (vascular endothelial growth factor) family. The VEGF family members regulate the formation of blood vessels and are involved in endothelial cell physiology. This member is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). Studies in mice showed that this gene was co-expressed with nuclear-encoded mitochondrial genes and the encoded protein specifically controlled endothelial uptake of fatty acids. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Sep 2011] |
UniProt Code: | P49765 |
NCBI GenInfo Identifier: | 17380554 |
NCBI Gene ID: | 7423 |
NCBI Accession: | P49765. 2 |
UniProt Secondary Accession: | P49765,Q16528, |
UniProt Related Accession: | P49765 |
Molecular Weight: | 21,261 Da |
NCBI Full Name: | Vascular endothelial growth factor B |
NCBI Synonym Full Names: | vascular endothelial growth factor B |
NCBI Official Symbol: | VEGFB |
NCBI Official Synonym Symbols: | VRF; VEGFL |
NCBI Protein Information: | vascular endothelial growth factor B |
UniProt Protein Name: | Vascular endothelial growth factor B |
UniProt Synonym Protein Names: | VEGF-related factor; VRF |
Protein Family: | Vascular endothelial growth factor |
UniProt Gene Name: | VEGFB |
UniProt Entry Name: | VEGFB_HUMAN |
As the RLU values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (pg/mL) | RLU | Average | Corrected |
500 | 48340 54734 | 51537 | 51508 |
250 | 18971 23025 | 20998 | 20969 |
125 | 9778 9014 | 9396 | 9367 |
62.5 | 4362 4662 | 4512 | 4483 |
31.25 | 2336 2262 | 2299 | 2270 |
15.63 | 1324 1176 | 1250 | 1221 |
7.81 | 716 764 | 740 | 711 |
0 | 29 29 | 29 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human VEGF-B were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human VEGF-B were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 25.51 | 48.61 | 186.56 | 27.35 | 46.31 | 191.85 |
Standard deviation | 3.24 | 4.78 | 20.54 | 2.83 | 5.04 | 20.22 |
C V (%) | 12.70 | 9.83 | 11.01 | 10.35 | 10.88 | 10.54 |
Recovery
The recovery of Human VEGF-B spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 96-112 | 102 |
EDTA plasma (n=5) | 95-109 | 102 |
Cell culture media (n=5) | 86-98 | 93 |
Linearity
Samples were spiked with high concentrations of Human VEGF-B and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 85-100 | 89-103 | 96-113 |
Average (%) | 92 | 96 | 103 | |
1:4 | Range (%) | 97-110 | 90-102 | 89-100 |
Average (%) | 103 | 95 | 95 | |
1:8 | Range (%) | 90-103 | 94-108 | 101-118 |
Average (%) | 96 | 102 | 109 | |
1:16 | Range (%) | 100-114 | 91-105 | 97-113 |
Average (%) | 107 | 98 | 105 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro CLIA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent A | 1 vial, 5 mL | 4°C (shading light) |
Substrate Reagent B | 1 vial, 5 mL | 4°C (shading light) |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids. ) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 100 µL of Substrate mixture solution to each well. Cover with a new plate seal andincubate for no more than 5 min at 37 °C. Protect the plate from light.
- Determine the RLU value of each well immediately.